Apollo Hospitals to buy 50 percent stake in AGHL for Rs 410 crore

In a regulatory filing, Apollo Hospitals said its Board has decided that the company would acquire 50 percent stake held by Gleneagles Development in the equal joint venture Rs 723 crore Apollo Gleneagles Hospitals.

Consequent to this development, Apollo Gleneagles would become a 100 percent wholly-owned subsidiary of the city-based Apollo Hospitals.

AGHL reportedly runs a 750-bed multi-speciality hospital in a 50:50 joint venture between Apollo Hospitals and IHH, which would sell its equity stake to Apollo Hospitals to exit the venture.

The acquisition is to be completed by December 15, reports IANS.

Similarly, the Apollo Hospitals Board also approved the acquisition of an additional one percent equity stake in Medics International Life Sciences Ltd, an unlisted public limited company which runs a 330 bedded multi-specialty hospital in Lucknow, in which it already holds a 50 percent equity stake for a consideration of Rs 39.76 million.

Consequent to this, Medics International Life Sciences will become a subsidiary of the company.

For the purposes of funding the acquisition of 50 percent stake in Apollo Gleneagles, Apollo Hospitals Board has also approved raising a sum of Rs 15 billion through issue of securities on a preferential basis and or through Qualified Institutional Placement (QIP) and also for any potential acquisitions, reduction of debt, for investments in technology upgradations and digital initiatives.

Also Read: Renowned Prosthodontist, IP University VC Dr Mahesh Verma Nominated As Director To The Board Running Indraprastha Apollo Hospital